Elevai Labs, Inc. is a public company focused on advancing health technology through innovative artificial intelligence solutions. The company specializes in developing AI-driven platforms that enhance medical diagnostics, treatment planning, and patient care. By leveraging machine learning algorithms and data analysis, Elevai Labs aims to improve the accuracy and efficiency of healthcare delivery, ultimately transforming the way medical professionals make decisions and interact with patients. Their commitment to research and development positions them at the forefront of a rapidly evolving sector, addressing critical challenges in healthcare with cutting-edge technology. Read More
PMGC's unit, NorthStrive Biosciences, filed 10 new U.S. patent applications for EL-22 and EL-32 technologies in the animal health and agriculture markets.
NEWPORT BEACH, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences, Inc. (“NorthStrive” or the “Company”), a wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced the filing of ten (10) new U.S. patent applications expanding its proprietary EL-22 and EL-32 technologies into animal health and agricultural markets, including applications designed to encourage animals to grow new muscle and increase muscle weight return per animal.
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- GB Capital Ltd. (“GB Capital”), a strategic finance, advisory and management firm, today announced that it served as co-advisor to PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC”) in connection with PMGC’s acquisition of SVM Machining, Inc. (“SVM”), a Northern California–based ISO 9001:2015 certified CNC precision machining company.
NEWPORT BEACH, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. (“NorthStrive”), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced that it has executed a definitive, exclusive license agreement (“License Agreement”) with Modulant Biosciences LLC (“Modulant”), following the previously announced binding term sheet dated May 12, 2025.
NEWPORT BEACH, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. (“NorthStrive Biosciences”), a subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB) (“PMGC”), today announced a progress update to the anticipated completion timeline for Phase III of its AI Development Program with strategic partner Yuva Biosciences, Inc. (“Yuva Biosciences”).
NEWPORT BEACH, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”), a diversified public holding company announced that it has completed the acquisition of SVM Machining, Inc. (“SVM”).
NEWPORT BEACH, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”), a diversified public holding company with multiple operating subsidiaries announces its investment arm PMGC Capital LLC. (“PMGC Capital”), has invested and acquired non-controlling shares in Nuclea Energy Inc. (“Nuclea Energy”), a company focused on the development and advancement of Micro Modular Reactor (MMR) and advanced nuclear energy solutions. The investment closed on November 6, 2025.
NEWPORT BEACH, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that, as previously disclosed on January 2, 2026, it will effect a 1-for-4 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 9:00 am, Eastern time, on January 6, 2026.
NEWPORT BEACH, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-4 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 9:00 am, Eastern time, on January 6, 2026.
NEWPORT BEACH, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC,” the “Company,” “we,” or “our”) today announced that its wholly owned subsidiary, AGA Precision Systems LLC (“AGA”), successfully achieved AS9100 certification, the globally recognized quality management standard specific to the aerospace, defense and space industries.
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
